Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective study. En savoir plus sur Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective study.
Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology. En savoir plus sur Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology.
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP). En savoir plus sur Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP).
Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective study. En savoir plus sur Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective study.
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial. En savoir plus sur Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study. En savoir plus sur Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.
Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study. En savoir plus sur Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study.
RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014. En savoir plus sur RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014.
[Metastatic colorectal cancer: To stop or not to stop?] En savoir plus sur [Metastatic colorectal cancer: To stop or not to stop?]
Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study. En savoir plus sur Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study.